177 related articles for article (PubMed ID: 15636684)
1. Preliminary assessment of magnetic resonance spectroscopic imaging in predicting treatment outcome in patients with prostate cancer at high risk for relapse.
Pucar D; Koutcher JA; Shah A; Dyke JP; Schwartz L; Thaler H; Kurhanewicz J; Scardino PT; Kelly WK; Hricak H; Zakian KL
Clin Prostate Cancer; 2004 Dec; 3(3):174-81. PubMed ID: 15636684
[TBL] [Abstract][Full Text] [Related]
2. Prostate MRSI predicts outcome in radical prostatectomy patients.
Zakian KL; Hatfield W; Aras O; Cao K; Yakar D; Goldman DA; Moskowitz CS; Shukla-Dave A; Tehrani YM; Fine S; Eastham J; Hricak H
Magn Reson Imaging; 2016 Jun; 34(5):674-81. PubMed ID: 26821278
[TBL] [Abstract][Full Text] [Related]
3. Localising prostate cancer: comparison of endorectal magnetic resonance (MR) imaging and 3D-MR spectroscopic imaging with transrectal ultrasound-guided biopsy.
Goris Gbenou MC; Peltier A; Addla SK; Lemort M; Bollens R; Larsimont D; Roumeguère T; Schulman CC; van Velthoven R
Urol Int; 2012; 88(1):12-7. PubMed ID: 22004874
[TBL] [Abstract][Full Text] [Related]
4. Locally advanced prostate cancer: three-dimensional magnetic resonance spectroscopy to monitor prostate response to therapy.
Valentini AL; Gui B; D'Agostino GR; Mattiucci G; Clementi V; Di Molfetta IV; Bonomo P; Mantini G
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):719-24. PubMed ID: 22436789
[TBL] [Abstract][Full Text] [Related]
5. The impact of the inclusion of endorectal coil magnetic resonance imaging in a multivariate analysis to predict clinically unsuspected extraprostatic cancer.
D'Amico AV; Whittington R; Schnall M; Malkowicz SB; Tomaszewski JE; Schultz D; Wein A
Cancer; 1995 May; 75(9):2368-72. PubMed ID: 7536124
[TBL] [Abstract][Full Text] [Related]
6. Endorectal magnetic resonance imaging as a predictor of biochemical outcome after radical prostatectomy in men with clinically localized prostate cancer.
D'Amico AV; Whittington R; Malkowicz B; Schnall M; Schultz D; Cote K; Tomaszewski JE; Wein A
J Urol; 2000 Sep; 164(3 Pt 1):759-63. PubMed ID: 10953141
[TBL] [Abstract][Full Text] [Related]
7. Prediction of prostate cancer recurrence using magnetic resonance imaging and molecular profiles.
Shukla-Dave A; Hricak H; Ishill N; Moskowitz CS; Drobnjak M; Reuter VE; Zakian KL; Scardino PT; Cordon-Cardo C
Clin Cancer Res; 2009 Jun; 15(11):3842-9. PubMed ID: 19435838
[TBL] [Abstract][Full Text] [Related]
8. Negative prostatic biopsies in patients with a high risk of prostate cancer. Is the combination of endorectal MRI and magnetic resonance spectroscopy imaging (MRSI) a useful tool? A preliminary study.
Amsellem-Ouazana D; Younes P; Conquy S; Peyromaure M; Flam T; Debré B; Zerbib M
Eur Urol; 2005 May; 47(5):582-6. PubMed ID: 15826747
[TBL] [Abstract][Full Text] [Related]
9. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
[TBL] [Abstract][Full Text] [Related]
10. Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.
Kupelian PA; Katcher J; Levin HS; Klein EA
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1043-52. PubMed ID: 9169811
[TBL] [Abstract][Full Text] [Related]
11. Combined magnetic resonance spectroscopy and dynamic contrast-enhanced imaging for prostate cancer detection.
Perdonà S; Di Lorenzo G; Autorino R; Buonerba C; De Sio M; Setola SV; Fusco R; Ronza FM; Caraglia M; Ferro M; Petrillo A
Urol Oncol; 2013 Aug; 31(6):761-5. PubMed ID: 21906966
[TBL] [Abstract][Full Text] [Related]
12. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment endorectal magnetic resonance imaging and magnetic resonance spectroscopic imaging features of prostate cancer as predictors of response to external beam radiotherapy.
Joseph T; McKenna DA; Westphalen AC; Coakley FV; Zhao S; Lu Y; Hsu IC; Roach M; Kurhanewicz J
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):665-71. PubMed ID: 18760545
[TBL] [Abstract][Full Text] [Related]
14. Predicting post-external beam radiation therapy PSA relapse of prostate cancer using pretreatment MRI.
Fuchsjäger MH; Pucar D; Zelefsky MJ; Zhang Z; Mo Q; Ben-Porat LS; Shukla-Dave A; Wang L; Reuter VE; Hricak H
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):743-50. PubMed ID: 20133067
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging of the prostate with spectroscopic imaging using a surface coil. Initial clinical experience.
Manenti G; Squillaci E; Carlani M; Mancino S; Di Roma M; Simonetti G
Radiol Med; 2006 Feb; 111(1):22-32. PubMed ID: 16623302
[TBL] [Abstract][Full Text] [Related]
16. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
17. Clinical utility of endorectal MRI in determining PSA outcome for patients with biopsy Gleason score 7, PSA Cheng GC; Chen MH; Whittington R; Malkowicz SB; Schnall MD; Tomaszewski JE; D'Amico AV
Int J Radiat Oncol Biol Phys; 2003 Jan; 55(1):64-70. PubMed ID: 12504037
[TBL] [Abstract][Full Text] [Related]
18. The Role of Magnetic Resonance Spectroscopy Imaging Parameters to Predict Early Biochemical Recurrence after Radical Prostatectomy.
Parizi MK; Razi A; Alizadeh S; Kasaeian A
Prague Med Rep; 2019; 120(2-3):74-83. PubMed ID: 31586506
[TBL] [Abstract][Full Text] [Related]
19. Prediction of extraprostatic cancer by prostate specific antigen density, endorectal MRI, and biopsy Gleason score in clinically localized prostate cancer.
Horiguchi A; Nakashima J; Horiguchi Y; Nakagawa K; Oya M; Ohigashi T; Marumo K; Murai M
Prostate; 2003 Jun; 56(1):23-9. PubMed ID: 12746843
[TBL] [Abstract][Full Text] [Related]
20. The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis.
Shukla-Dave A; Hricak H; Kattan MW; Pucar D; Kuroiwa K; Chen HN; Spector J; Koutcher JA; Zakian KL; Scardino PT
BJU Int; 2007 Apr; 99(4):786-93. PubMed ID: 17223922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
